105 related articles for article (PubMed ID: 38740853)
21. Oral cancer - the fight must go on against all odds….
Evid Based Dent; 2022 Mar; 23(1):4-5. PubMed ID: 35338315
[No Abstract] [Full Text] [Related]
22. Eugenol Inhibits the Biological Activities of an Oral Squamous Cell Carcinoma Cell Line SCC9
Duan Y; Huang X; Qiao B; Ma R; Li J
Anticancer Agents Med Chem; 2022 Aug; 22(15):2799-2806. PubMed ID: 35331101
[TBL] [Abstract][Full Text] [Related]
23. GSDME Is Related to Prognosis and Response to Chemotherapy in Oral Cancer.
Wang S; Zhang MJ; Wu ZZ; Zhu SW; Wan SC; Zhang BX; Yang QC; Xiao Y; Chen L; Sun ZJ
J Dent Res; 2022 Jul; 101(7):848-858. PubMed ID: 35148659
[TBL] [Abstract][Full Text] [Related]
24. Cyclin E/CDK2: DNA Replication, Replication Stress and Genomic Instability.
Fagundes R; Teixeira LK
Front Cell Dev Biol; 2021; 9():774845. PubMed ID: 34901021
[TBL] [Abstract][Full Text] [Related]
25. Anticancer Properties of Eugenol: A Review.
Zari AT; Zari TA; Hakeem KR
Molecules; 2021 Dec; 26(23):. PubMed ID: 34885992
[TBL] [Abstract][Full Text] [Related]
26. The NUCKS1-SKP2-p21/p27 axis controls S phase entry.
Hume S; Grou CP; Lascaux P; D'Angiolella V; Legrand AJ; Ramadan K; Dianov GL
Nat Commun; 2021 Nov; 12(1):6959. PubMed ID: 34845229
[TBL] [Abstract][Full Text] [Related]
27. The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Cheng Y; Li S; Gao L; Zhi K; Ren W
Front Oncol; 2021; 11():761379. PubMed ID: 34746001
[TBL] [Abstract][Full Text] [Related]
28. Role of Phytochemicals in Cancer Chemoprevention: Insights.
George BP; Chandran R; Abrahamse H
Antioxidants (Basel); 2021 Sep; 10(9):. PubMed ID: 34573087
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological Properties and Health Benefits of Eugenol: A Comprehensive Review.
Nisar MF; Khadim M; Rafiq M; Chen J; Yang Y; Wan CC
Oxid Med Cell Longev; 2021; 2021():2497354. PubMed ID: 34394824
[TBL] [Abstract][Full Text] [Related]
30. Overview of oral cavity squamous cell carcinoma: Risk factors, mechanisms, and diagnostics.
Chamoli A; Gosavi AS; Shirwadkar UP; Wangdale KV; Behera SK; Kurrey NK; Kalia K; Mandoli A
Oral Oncol; 2021 Oct; 121():105451. PubMed ID: 34329869
[TBL] [Abstract][Full Text] [Related]
31. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition.
Sha J; Bai Y; Ngo HX; Okui T; Kanno T
Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34208465
[TBL] [Abstract][Full Text] [Related]
32. Anethole induces anti-oral cancer activity by triggering apoptosis, autophagy and oxidative stress and by modulation of multiple signaling pathways.
Contant C; Rouabhia M; Loubaki L; Chandad F; Semlali A
Sci Rep; 2021 Jun; 11(1):13087. PubMed ID: 34158560
[TBL] [Abstract][Full Text] [Related]
33. Effects of tetrahydrocannabinols on human oral cancer cell proliferation, apoptosis, autophagy, oxidative stress, and DNA damage.
Semlali A; Beji S; Ajala I; Rouabhia M
Arch Oral Biol; 2021 Sep; 129():105200. PubMed ID: 34146926
[TBL] [Abstract][Full Text] [Related]
34. Breast Cancer Resistance to Cyclin-Dependent Kinases 4/6 Inhibitors: Intricacy of the Molecular Mechanisms.
Wang B; Li R; Wu S; Liu X; Ren J; Li J; Bi K; Wang Y; Jia H
Front Oncol; 2021; 11():651541. PubMed ID: 34123801
[TBL] [Abstract][Full Text] [Related]
35. The curcumin analog (PAC) suppressed cell survival and induced apoptosis and autophagy in oral cancer cells.
Semlali A; Contant C; Al-Otaibi B; Al-Jammaz I; Chandad F
Sci Rep; 2021 Jun; 11(1):11701. PubMed ID: 34083581
[TBL] [Abstract][Full Text] [Related]
36. Oral Cancer Screening: Past, Present, and Future.
Warnakulasuriya S; Kerr AR
J Dent Res; 2021 Nov; 100(12):1313-1320. PubMed ID: 34036828
[TBL] [Abstract][Full Text] [Related]
37. Biological Properties and Prospects for the Application of Eugenol-A Review.
Ulanowska M; Olas B
Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33916044
[TBL] [Abstract][Full Text] [Related]
38. Pleiotropic Effects of Eugenol: The Good, the Bad, and the Unknown.
Aburel OM; Pavel IZ; Dănilă MD; Lelcu T; Roi A; Lighezan R; Muntean DM; Rusu LC
Oxid Med Cell Longev; 2021; 2021():3165159. PubMed ID: 33747344
[TBL] [Abstract][Full Text] [Related]
39.
Varadarajan S; Narasimhan M; Balaji TM; Chamundeeswari DP; Sakthisekaran D
J Contemp Dent Pract; 2020 Sep; 21(9):1027-1033. PubMed ID: 33568591
[TBL] [Abstract][Full Text] [Related]
40. Cyclin F Downregulation Affects Epithelial-Mesenchymal Transition Increasing Proliferation and Migration of the A-375 Melanoma Cell Line.
Krajewski A; Gagat M; Mikołajczyk K; Izdebska M; Żuryń A; Grzanka A
Cancer Manag Res; 2020; 12():13085-13097. PubMed ID: 33376401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
